Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
117 GBX | +3.36% |
|
+7.54% | -5.19% |
Jul. 03 | Syncona Invests Additional $42.5 Million in Beacon Therapeutics | MT |
Jul. 03 | Syncona's portfolio Beacon Therapeutics raises USD170 million | AN |
Business Summary
Number of employees: 1,050
Sales per Business
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100.0
%
| 40 | 100.0 % | 42 | 100.0 % | +5.25% |
Sales per region
GBP in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
100.0
%
| 40 | 100.0 % | 42 | 100.0 % | +5.25% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Annabel Clark
IRC | Investor Relations Contact | - | 18-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 22-01-31 | |
Virginia Holmes
BRD | Director/Board Member | 64 | 20-12-31 |
Kemal Malik
BRD | Director/Board Member | 61 | 20-06-14 |
Melanie Gee
CHM | Chairman | 63 | 19-06-03 |
Cristina Csimma
BRD | Director/Board Member | 65 | 22-01-31 |
Gian Reverberi
BRD | Director/Board Member | 58 | 18-03-31 |
Director/Board Member | - | 17-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 661,731,666 | 631,332,440 ( 95.41 %) | 16,471,080 ( 2.489 %) | 95.41 % |
Company contact information
![address Syncona Limited(BACT)](https://cdn.zonebourse.com/static/address/11814171.png)
Group companies
Name | Category and Sector |
---|---|
Syncona Investments LP, Inc.
![]() Syncona Investments LP, Inc. Financial ConglomeratesFinance Part of Syncona Ltd., Syncona Investments LP, Inc. provides investment services. The company is located in UK. |
Financial Conglomerates
|
Biotechnology
| |
Syncona Portfolio Ltd.
| |
Syncona Investment Management Ltd.
![]() Syncona Investment Management Ltd. Investment ManagersFinance Syncona Investment Management Ltd. (Syncona) is the asset management subsidiary of Syncona Ltd. in Great Britain. Headquartered in London, the firm was co-founded by Martin Murphy alongside The Wellcome Trust. Syncona is focused on founding, building and funding a portfolio of global leaders in life science. |
Investment Managers
|
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.19% | 967M | |
+24.10% | 84.25B | |
+11.67% | 17.86B | |
+61.85% | 17.81B | |
+7.94% | 14.57B | |
+25.65% | 12.85B | |
-2.86% | 12.6B | |
+41.12% | 11.13B | |
-1.05% | 11.01B | |
+98.10% | 10.07B |
- Stock Market
- Equities
- BACT Stock
- Company Syncona Limited